Literature DB >> 65160

Aldolases of the lactic acid bacteria. Demonstration of immunological relationships among eight genera of Gram positive bacteria using an anti-pediococcal aldolase serum.

J London, N M Chace.   

Abstract

Reciprocal qualitative and quantitative immunological experiments employing an anti-Pediococcus cerevisiae aldolase serum confirmed many of the interspecific relationships demonstrated previously among lactic acid bacteria with antisera prepared against the Streptococcus faecalis fructose diphosphate aldolase. The extent of immunological relatedness observed between the Lactobacillus and Pediococcus aldolases was markedly gses indicating that the pediococci share closer phylogenetic ties with the rod-shaped lacotbacilli than with their spherical counterparts in the streptococci. In addition to confirming the existence of definitive, but distant, relationships between the lactic acid bacteria and certain gram positive nonsporeforming anaerobes, immunological cross-reactivity was also demonstrated between the pediococcal aldolases and those of Aerococcus viridans.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 65160     DOI: 10.1007/BF00416976

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  10 in total

1.  ANTICOMPLEMENTARY EFFECTS AND COMPLEMENT ACTIVITY OF HUMAN SERA.

Authors:  W A HOOK; L H MUSCHEL
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition.

Authors:  E WASSERMAN; L LEVINE
Journal:  J Immunol       Date:  1961-09       Impact factor: 5.422

3.  Determination of serum proteins by means of the biuret reaction.

Authors:  A G GORNALL; C J BARDAWILL; M M DAVID
Journal:  J Biol Chem       Date:  1949-02       Impact factor: 5.157

4.  Quantitative immunochemistry and the evolution of primate albumins: micro-complement fixation.

Authors:  V M Sarich; A C Wilson
Journal:  Science       Date:  1966-12-23       Impact factor: 47.728

5.  Aldolase of lactic acid bacteria: a case history in the use of an enzyme as an evolutionary marker.

Authors:  J London; K Kline
Journal:  Bacteriol Rev       Date:  1973-12

6.  Variations in the quaternary structure of three lactic acid bacteria aldolases. Evidence for the existence of a class I and class II aldolase in Lactobacillus casei.

Authors:  J London
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

7.  Immunological comparison of azurins of known amino acid sequence. Dependence of cross-reactivity upon sequence resemblance.

Authors:  A B Champion; K L Soderberg; A C Wilson
Journal:  J Mol Evol       Date:  1975-09-08       Impact factor: 2.395

8.  The dependence of immunological cross-reactivity upon sequence resemblance among lysozymes. II. Comparison of precipitin and micro-complement fixation results.

Authors:  E M Prager; A C Wilson
Journal:  J Biol Chem       Date:  1971-11-25       Impact factor: 5.157

9.  Immunological relationships among lactic dehydrogenases in the genera Lactobacillus and Leuconostoc.

Authors:  F Gasser; C Gasser
Journal:  J Bacteriol       Date:  1971-04       Impact factor: 3.490

10.  Comparative biochemical and immunological study of malic enzyme from two species of lactic acid bacteria: evolutionary implications.

Authors:  J London; E Y Meyer; S Kulczyk
Journal:  J Bacteriol       Date:  1971-04       Impact factor: 3.490

  10 in total
  3 in total

1.  Clinical and microbiologic characteristics of pediococci.

Authors:  W J Riebel; J A Washington
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 2.  Polyphasic taxonomy, a consensus approach to bacterial systematics.

Authors:  P Vandamme; B Pot; M Gillis; P de Vos; K Kersters; J Swings
Journal:  Microbiol Rev       Date:  1996-06

3.  Origins of the mycoplasmas: sterol-nonrequiring mycoplasmas evolved from streptococci.

Authors:  H Neimark; J London
Journal:  J Bacteriol       Date:  1982-06       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.